OrsoBio

Privately held: no public share price · United States

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Phase 2
Liver X receptor (LXR)Small molecule
Cardiovascular Disease / Dyslipidemia
Hypertriglyceridemia
Phase 1
Mitochondrial uncouplingSmall molecule
Obesity

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.